Aardvark Therapeutics, Inc.
10-K
March 23, 2026
Key Highlights
- Successful IPO in Feb 2025 raising $87.5 million in net proceeds, providing sign...
- ARD-101 advanced to a pivotal Phase 3 HERO trial for Prader-Willi Syndrome (PWS)...
- Positive Phase 2 data for ARD-101 showed it was well-tolerated, reduced hunger, ...
Read Analysis
🤖 AI Generated